Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes

NCT01690091 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.

NCT NCT01690091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01690091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes
Lead sponsor
Institute for Clinical and Experimental Medicine
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2012
Completion date
December 31, 2016
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure, insulin resistance